| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Immunology and Pathology |
* Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York; Medical Associates of Drexel Hill, Inc., Drexel Hill, Pennsylvania; Saint Peters University Hospital, New Brunswick, New Jersey; Catskill Regional Medical Center, Harris, New York; || Department of Medicine, Christian Care Health Services, Newark, Delaware; ¶ Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania; ** Department of Medicine, St. Lukes Hospital, Bethlehem, Pennsylvania; and Queens-Nassau Nephrology Services PLLC, Garden City, New York
Correspondence: Dr. Samih H. Nasr, Department of Pathology, Columbia University, College of Physicians & Surgeons, 630 West 168th Street, VC14-224, New York, NY 10032. Phone: 212-305-7460; Fax: 212-342-5380; E-mail: sn386{at}columbia.edu
Background and objectives: Lupus nephritis is a classic immune complex glomerulonephritis. In contrast, antineutrophil cytoplasmic antibodies are associated with necrotizing and crescentic glomerulonephritis, in the absence of significant immune deposits. Antineutrophil cytoplasmic antibodies are detected by indirect immunofluorescence in 20% of patients with systemic lupus erythematosus. We report 10 cases of necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.
Design, setting, participants, & measurements: Ten patients with systemic lupus erythematosus, antineutrophil cytoplasmic antibody positivity, and renal biopsy findings of lupus nephritis and antineutrophil cytoplasmic antibody–associated glomerulonephritis were identified. The clinical features, pathologic findings, and outcomes are described.
Results: The cohort consisted of eight women and two men with a mean age of 48.4 yr. Perinuclear antineutrophil cytoplasmic antibody was detected by indirect immunofluorescence in nine patients. Four of the nine patients and the single remaining patient were found to have myeloperoxidase–antineutrophil cytoplasmic antibodies by enzyme-linked immunosorbent assay. Clinical presentation included proteinuria, hematuria, and acute renal insufficiency, with mean creatinine of 7.1 mg/dl. All biopsies exhibited prominent necrosis and crescents with absent or rare subendothelial deposits and were interpreted as lupus nephritis and antineutrophil cytoplasmic antibody–associated glomerulonephritis. All patients received cyclophosphamide and prednisone. Three patients died of infectious complications. Among the remaining seven patients, five achieved a complete or near-complete remission, one had a remission with subsequent relapse, and one had no response to therapy.
Conclusion: Antineutrophil cytoplasmic antibody–associated necrotizing and crescentic glomerulonephritis may occur superimposed on lupus nephritis. In patients with lupus nephritis and biopsy findings of prominent necrosis and crescent formation in the absence of significant endocapillary proliferation or subendothelial deposits, antineutrophil cytoplasmic antibody testing by enzyme-linked immunosorbent assay is recommended.
This article has been cited by other articles:
|
|
 |
|
  S. H. Nasr, S. M. Said, A. M. Valeri, M. B. Stokes, N. N. Masani, V. D. D'Agati, and G. S. Markowitz Membranous Glomerulonephritis with ANCA-Associated Necrotizing and Crescentic Glomerulonephritis Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 299 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Glassock Multitarget Therapy of Lupus Nephritis: Base Hit or Home Run? J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1842 - 1844. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
